Biosyntech (Biosyntech) Gross Profit : $0.12 Mil (TTM As of Dec. 2009)

Biosyntech Gross Profit Chart

Biosyntech Annual Data
	Trend	Mar00	Mar01	Mar02	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09
Gross Profit		Get a 7-Day Free Trial					0.08	0.04	0.13	0.17	0.02

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Gross Profit	Get a 7-Day Free Trial															-	0.01	0.03	0.08	-

Competitive Comparison of Biosyntech's Gross Profit

For the Biotechnology subindustry, Biosyntech's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosyntech's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's Gross Profit distribution charts can be found below:

* The bar in red indicates where Biosyntech's Gross Profit falls into.

Biosyntech Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Biosyntech's Gross Profit for the fiscal year that ended in Mar. 2009 is calculated as

Biosyntech's Gross Profit for the quarter that ended in Dec. 2009 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Biosyntech's Gross Margin % for the quarter that ended in Dec. 2009 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Biosyntech  (OTCPK:BSYI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biosyntech had a gross margin of 0.00% for the quarter that ended in Dec. 2009 => No sustainable competitive advantage

Biosyntech Gross Profit Related Terms

Thank you for viewing the detailed overview of Biosyntech's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description